This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Energesis Pharmaceuticals, Inc.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Mihaela Crisan: Innovator in Brown Adipose Tissue Research
Introduction
Mihaela Crisan is a prominent inventor based in Rotterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the study of brown adipose tissue (BAT) progenitor cells. With two patents to her name, her work is paving the way for advancements in medical science.
Latest Patents
Crisan's latest patents focus on the isolation and differentiation of brown adipocyte progenitor cells from human skeletal muscle. These inventions provide methods for identifying BAT progenitor cell surface markers and developing mediums and agents that induce cell differentiation into brown adipocytes. The patents detail that the BAT progenitor cells express specific surface markers associated with endothelial cells, which can be detected through antibody-based assays. Furthermore, these progenitor cells can be substantially free of other endothelial cell markers, enhancing their potential for therapeutic applications.
Career Highlights
Mihaela Crisan is currently associated with Energesis Pharmaceuticals, Inc., where she continues her research and development efforts. Her work is instrumental in understanding the role of brown adipose tissue in metabolism and its implications for obesity and related diseases.
Collaborations
Crisan collaborates with notable colleagues, including Olivier D Boss and Jean-Paul Giacobino, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mihaela Crisan's contributions to the field of biotechnology, particularly in brown adipose tissue research, highlight her role as a leading inventor. Her patents and ongoing work at Energesis Pharmaceuticals, Inc. are set to make a significant impact on medical science and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile